Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.020
+0.030 (1.50%)
At close: Dec 26, 2025
Medexus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 0.38 | 2.25 | -0.21 | 1.22 | -2.88 | -28.26 | Upgrade |
Depreciation & Amortization | 9.05 | 7.18 | 5.81 | 6.08 | 6.14 | 5.98 | Upgrade |
Other Amortization | - | - | - | - | 0 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | 0.34 | 2.8 | 0.89 | - | 1.75 | - | Upgrade |
Stock-Based Compensation | 0.17 | 0.41 | 0.47 | 1.22 | 1.88 | 1.27 | Upgrade |
Other Operating Activities | 4.51 | 5.55 | 9.42 | 5.3 | -12.81 | 25.88 | Upgrade |
Change in Accounts Receivable | 10.54 | 10.54 | -1.68 | -8.24 | 4.43 | -3.51 | Upgrade |
Change in Inventory | -4.6 | -4.6 | -6.75 | -1.99 | -6.66 | -0.01 | Upgrade |
Change in Accounts Payable | -1.99 | -1.99 | 8.58 | 4.75 | 3.61 | 4.63 | Upgrade |
Change in Other Net Operating Assets | -1.75 | 1.9 | 2.19 | -9.79 | 3.36 | -0.93 | Upgrade |
Operating Cash Flow | 16.24 | 24.03 | 18.71 | -1.44 | -1.18 | 5.04 | Upgrade |
Operating Cash Flow Growth | -26.82% | 28.43% | - | - | - | - | Upgrade |
Capital Expenditures | -0.25 | -0.18 | -0.05 | -0.06 | -0.1 | -0.12 | Upgrade |
Cash Acquisitions | -4.4 | -3.28 | -3.21 | -1.36 | -0.48 | -0.95 | Upgrade |
Sale (Purchase) of Intangibles | -2.54 | -2.54 | -0.22 | -0.3 | -7.62 | -10.64 | Upgrade |
Investing Cash Flow | -6.54 | -6 | -3.48 | -1.72 | -8.2 | -11.71 | Upgrade |
Long-Term Debt Issued | - | - | 17.58 | 35.46 | 3.89 | 0.35 | Upgrade |
Long-Term Debt Repaid | - | -14.24 | -43.99 | -24.72 | -0.16 | -0.37 | Upgrade |
Net Debt Issued (Repaid) | -23.43 | -14.24 | -26.4 | 10.73 | 3.73 | -0.02 | Upgrade |
Issuance of Common Stock | 19.3 | 19.3 | 7.61 | - | - | 22.64 | Upgrade |
Other Financing Activities | -3.06 | -4.27 | -4.25 | -4.33 | -3.07 | -3.93 | Upgrade |
Financing Cash Flow | -7.19 | 0.8 | -23.05 | 6.41 | 0.66 | 18.68 | Upgrade |
Foreign Exchange Rate Adjustments | -0.11 | -0.11 | -0 | -0.19 | 0.03 | 1.45 | Upgrade |
Net Cash Flow | 2.41 | 18.72 | -7.81 | 3.05 | -8.69 | 13.47 | Upgrade |
Free Cash Flow | 16 | 23.85 | 18.66 | -1.51 | -1.28 | 4.92 | Upgrade |
Free Cash Flow Growth | -27.69% | 27.79% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 15.37% | 22.02% | 16.51% | -1.39% | -1.67% | 6.18% | Upgrade |
Free Cash Flow Per Share | 0.53 | 0.90 | 0.84 | -0.07 | -0.06 | 0.32 | Upgrade |
Cash Interest Paid | 3.06 | 4.27 | 4.25 | 4.33 | 3.07 | 3.64 | Upgrade |
Cash Income Tax Paid | 0.15 | 0.22 | 1.42 | 0.91 | 0.68 | 0.87 | Upgrade |
Levered Free Cash Flow | 19.06 | 28.32 | 8.47 | -8.98 | -10.18 | -8.96 | Upgrade |
Unlevered Free Cash Flow | 23.32 | 33.44 | 16.83 | -0.48 | -2.54 | -2.82 | Upgrade |
Change in Working Capital | 2.2 | 5.84 | 2.34 | -15.26 | 4.73 | 0.18 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.